P3 Health Partners Inc.

PIII

CIK 0001832511 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$385M
↑+3.8% +$14Mvs FY2024 (Q4)
Operating Income
$364M
↑+4.2% +$15Mvs FY2024 (Q4)
Net Income
$362M
↑+5.3% +$18Mvs FY2024 (Q4)
Gross Profit
$385M
↑+3.8% +$14Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
55/100
  • Profitability
    0ROIC -165.5% (10% = solid, 20%+ = moat)
  • Liquidity
    0Current Ratio 0.24 (above 1.5 = solid)
  • Leverage
    100D/E -1.47 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 2.03x (1.0+ = capital-efficient)
  • Growth
    29Revenue YoY +3.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -12.8% · trend +5.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$119K
investment in PP&E
Stock-based comp (TTM)
$6M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$657M
everything owned
Total liabilities
$797M
everything owed
Stockholders' equity
$-155M
shareholder claim
Net debt
$203M
LT debt minus cash

Recent performance · 23 quarters

Revenue↑+3.8% +$14M
$385M
Net Income↑+32.1% +$15M
$-32M
Free Cash Flow
$-119K
Operating Margin↑+16.7pts
-12.8%

Drill down